Our technology, ID.Flow, utilizes freshly donated human blood to help researchers better understand drug-induced immune reactions during non-clinical development. By improving the accuracy and relevance of safety and efficacy assessments, we reduce the need for animal studies and enhance the translatability of preclinical findings.
Looking for a particular Immuneed employee's phone or email?
The Immuneed annual revenue was $1 million in 2026.
Alexander Kovacs is the CEO of Immuneed.
12 people are employed at Immuneed.
Immuneed is based in Uppsala, Uppsala.
The NAICS codes for Immuneed are [5417, 54, 54171, 541713, 541].
The SIC codes for Immuneed are [87, 873].